Quanterix (NASDAQ:QTRX) Sets New 12-Month Low at $31.86

Quanterix Co. (NASDAQ:QTRX) hit a new 52-week low during trading on Friday . The stock traded as low as $31.86 and last traded at $31.86, with a volume of 489 shares traded. The stock had previously closed at $33.09.

Separately, Zacks Investment Research downgraded shares of Quanterix from a “hold” rating to a “sell” rating in a research note on Wednesday, November 10th.

The company’s 50-day simple moving average is $43.16 and its 200-day simple moving average is $48.59.

Quanterix (NASDAQ:QTRX) last released its earnings results on Thursday, November 4th. The company reported ($0.43) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.30) by ($0.13). Quanterix had a negative net margin of 44.63% and a negative return on equity of 11.88%. The business had revenue of $26.68 million for the quarter, compared to analysts’ expectations of $23.84 million. During the same quarter last year, the company posted $0.07 earnings per share. On average, research analysts predict that Quanterix Co. will post -1.79 earnings per share for the current fiscal year.

In related news, CEO E Kevin Hrusovsky sold 5,000 shares of Quanterix stock in a transaction dated Friday, October 22nd. The stock was sold at an average price of $50.70, for a total transaction of $253,500.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP David C. Duffy sold 1,667 shares of the stock in a transaction on Wednesday, December 29th. The shares were sold at an average price of $40.71, for a total value of $67,863.57. The disclosure for this sale can be found here. Insiders have sold 30,737 shares of company stock worth $1,572,430 over the last three months. Corporate insiders own 15.40% of the company’s stock.

Several institutional investors have recently made changes to their positions in the company. FORA Capital LLC raised its stake in shares of Quanterix by 326.5% in the 2nd quarter. FORA Capital LLC now owns 1,224 shares of the company’s stock valued at $72,000 after acquiring an additional 937 shares in the last quarter. US Bancorp DE increased its position in Quanterix by 103.1% in the 2nd quarter. US Bancorp DE now owns 1,489 shares of the company’s stock worth $87,000 after buying an additional 756 shares during the period. Advisor Group Holdings Inc. increased its position in shares of Quanterix by 1,459.2% during the second quarter. Advisor Group Holdings Inc. now owns 1,606 shares of the company’s stock valued at $93,000 after purchasing an additional 1,503 shares during the period. PNC Financial Services Group Inc. increased its position in shares of Quanterix by 49.3% during the second quarter. PNC Financial Services Group Inc. now owns 1,587 shares of the company’s stock valued at $93,000 after purchasing an additional 524 shares during the period. Finally, Nisa Investment Advisors LLC increased its position in shares of Quanterix by 36.0% during the second quarter. Nisa Investment Advisors LLC now owns 1,700 shares of the company’s stock valued at $100,000 after purchasing an additional 450 shares during the period. Institutional investors and hedge funds own 84.06% of the company’s stock.

Quanterix Company Profile (NASDAQ:QTRX)

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development.

Further Reading: How is the S&P 500 index different from the DJIA?

Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.